Company: RPID
Filing Date: 2025-05-09
Form Type: 10-Q
Source: 0001380106-25-000102
Chunk: 267

Company: RAPID MICRO BIOSYSTEMS, INC.
Filing Date: 2025-05-09
Form: 10-Q
Item: Part I, Item 1
Chunk 267
---
— 23 23 Balances at March 31, 202437,483,559 375 5,309,529 53 547,300 (441,707)(78)105,943 

The accompanying notes are an integral part of these condensed consolidated financial statements.

9

Table of Contents

RAPID MICRO BIOSYSTEMS, INC.

Condensed consolidated statements of cash flows

(Unaudited)

(In thousands)

Three Months Ended March 31,20252024Cash flows from operating activities:Net loss$(11,263)$(13,322)Adjustments to reconcile net loss to net cash used in operating activities:Depreciation and amortization expense847 806 Loss on fixed asset impairment19 — Stock-based compensation expense1,042 1,085 Provision for excess and obsolete inventory235 85 Noncash lease expense305 305 Accretion on investments32 (500)Other9 8 Changes in operating assets and liabilities:Accounts receivable2,998 611 Inventory(1,075)(543)Prepaid expenses and other current assets196 (415)Accounts payable100 (809)Accrued expenses and other current liabilities(2,003)(3,095)Deferred revenue(507)259 Net cash used in operating activities(9,065)(15,525)Cash flows from investing activities:Purchases of property and equipment(319)(585)Purchases of investments— (4,380)Maturity of investments11,000 18,480 Net cash provided by investing activities10,681 13,515 Cash flows from financing activities:Proceeds from issuance of Class A common stock - stock option exercise296 — Proceeds from issuance of Class A common stock - employee stock purchase plan90 168 Payments on finance lease obligations(7)(10)Net cash provided by financing activities379 158 Net decrease in cash, cash equivalents and restricted cash1,995 (1,852)Cash, cash equivalents and restricted cash at beginning of period17,276 24,569 Cash, cash equivalents and restricted cash at end of period$19,271 $22,717 

Three Months Ended March 31,20252024Supplemental disclosure of cash flow informationCash paid for interest$12 $9 Supplemental disclosure of non-cash investing activitiesPurchases of property and equipment in accounts payable and accrued expenses$106 $348